Ensign Peak Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,152
| Closed | -$608K | – | 2243 |
|
|
2022
Q3 | $608K | Hold |
42,152
| – | – | ﹤0.01% | 1359 |
|
|
2022
Q2 | $638K | Buy |
42,152
+37,812
| +871% | +$572K | ﹤0.01% | 1336 |
|
|
2022
Q1 | $52K | Hold |
4,340
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q4 | $70K | Sell |
4,340
-1,703
| -28% | -$27.5K | ﹤0.01% | 2113 |
|
|
2021
Q3 | $172K | Sell |
6,043
-16,555
| -73% | -$471K | ﹤0.01% | 1763 |
|
|
2021
Q2 | $764K | Hold |
22,598
| – | – | ﹤0.01% | 1507 |
|
|
2021
Q1 | $684K | Sell |
22,598
-6,750
| -23% | -$204K | ﹤0.01% | 1534 |
|
|
2020
Q4 | $1.45M | Sell |
29,348
-2,831
| -9% | -$140K | ﹤0.01% | 1227 |
|
|
2020
Q3 | $1.24M | Buy |
32,179
+28,398
| +751% | +$1.09M | ﹤0.01% | 1214 |
|
|
2020
Q2 | $163K | Hold |
3,781
| – | – | ﹤0.01% | 1600 |
|
|
2020
Q1 | $99K | Sell |
3,781
-5,020
| -57% | -$131K | ﹤0.01% | 1579 |
|
|
2019
Q4 | $275K | Buy |
+8,801
| New | +$275K | ﹤0.01% | 1599 |
|